Qun Yin
30Patents
7h-index
25Co-inventors
69Inventor score
Filing activity: Dec 11, 1996 → Aug 11, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5869451A | Peptides and compounds that bind to a receptor | Human Necessities | 112 | Expired |
| US6251864A | Peptides and compounds that bind to a receptor | Chemistry; Metallurgy | 78 | Expired |
| US7084245B2 | Peptides that bind to the erythropoietin receptor | Chemistry; Metallurgy | 35 | Expired |
| US6121238A | Peptides and compounds that bind to a receptor | Human Necessities | 31 | Expired |
| US6506362B1 | Labeled compounds that bind to a thrombopoietin receptor | Chemistry; Metallurgy | 18 | Expired |
| US9840493B2 | Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use | Chemistry; Metallurgy | 17 | Active |
| US7528104B2 | Peptides that bind to the erythropoietin receptor | Human Necessities | 7 | Expired |
| US8377880B2 | Therapeutic agents for reducing parathyroid hormone levels | Human Necessities | 7 | Active |
| US8999932B2 | Therapeutic agents for reducing parathyroid hormone levels | Human Necessities | 6 | Active |
| US7109299B1 | Peptides and compounds that bind to the IL-5 receptor | Chemistry; Metallurgy | 5 | Expired |
| US9701712B2 | Therapeutic agents for reducing parathyroid hormone levels | Human Necessities | 4 | Active |
| US9278995B2 | Therapeutic agents for reducing parathyroid hormone levels | Human Necessities | 4 | Active |
| US9820938B2 | Stable liquid formulation of AMG 416 (etelcalcetide) | Mechanical Engineering; Lighting; Heating | 3 | Active |
| US10344765B2 | Stable liquid formulation of AMG 416 (etelcalcetide) | Mechanical Engineering; Lighting; Heating | 2 | Active |
| US7414105B2 | Peptides that bind to the erythropoietin receptor | Chemistry; Metallurgy | 2 | Expired |
| US10442789B2 | Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use | Chemistry; Metallurgy | 2 | Active |
| US9567370B2 | Therapeutic agents for reducing parathyroid hormone levels | Human Necessities | 1 | Active |
| US10844090B2 | Hemiasterlin derivatives for conjugation and therapy | Chemistry; Metallurgy | 1 | Active |
| US7919118B2 | Spacer moiety for poly (ethylene glycol) modified peptide based compounds | Chemistry; Metallurgy | 1 | Active |
| US8304391B2 | Peptides that bind to the erythropoietin receptor | Human Necessities | 1 | Active |
| US7855175B2 | Peptides that bind to the erythropoietin receptor | Chemistry; Metallurgy | 1 | Active |
| US11162500B2 | Stable liquid formulation of AMG 416 (etelcalcetide) | Human Necessities | 0 | Active |
| US8017583B2 | Methods of use of epsilon inhibitor compounds for the attenuation of pain | Chemistry; Metallurgy | 0 | Active |
| US11959486B2 | Stable liquid formulation of AMG 416 (etelcalcetide) | Mechanical Engineering; Lighting; Heating | 0 | Active |
| US10280198B2 | Therapeutic agents for reducing parathyroid hormone levels | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.